Correction: Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/ Akt signaling pathway in gastric cancer.

Xu, Jiahui; Liu, Deying; Niu, Huilin; Zhu, Guifang; Xu, Yangwei; Ye, Danli; Li, Jian; Zhang, Qingling

Xu, Jiahui; Liu, Deying; Niu, Huilin; Zhu, Guifang; Xu, Yangwei; Ye, Danli; Li, Jian; Zhang, Qingling.

Afiliação

Xu J; Nanfang Hospital/First Clinical Medical School, Southern Medical University, Guangzhou, 510515, China.
Liu D; Nanfang Hospital/First Clinical Medical School, Southern Medical University, Guangzhou, 510515, China.
Niu H; Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.
Zhu G; Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.
Xu Y; Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.
Ye D; Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.
Li J; Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.
Zhang Q; Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China. zqllc8@126.com.

J Exp Clin Cancer Res ; 42(1): 23, 2023 Jan 17.

Article em En | MEDLINE | ID: mdl-36647144

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Estomago Base de dados: MEDLINE Idioma: En Revista: J Exp Clin Cancer Res Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google